The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Tissue Engineered Bone Grafts: Biological Requirements, Tissue Culture and Clinical Relevance
Open accessAbstract
The tremendous need for bone tissue in numerous clinical situations and the limited availability of suitable bone grafts are driving the development of tissue engineering approaches to bone repair. In order to engineer viable bone grafts, one needs to understand the mechanisms of native bone development and fracture healing, as these processes should ideally guide the selection of optimal conditions for tissue culture and implantation. Engineered bone grafts have been shown to have capacity for osteogenesis, osteoconduction, osteoinduction and osteointegration - functional connection between the host bone and the graft. Cells from various anatomical sources in conjunction with scaffolds and osteogenic factors have been shown to form bone tissue in vitro. The use of bioreactor systems to culture cells on scaffolds before implantation further improved the quality of the resulting bone grafts. Animal studies confirmed the capability of engineered grafts to form bone and integrate with the host tissues. However, the vascularization of bone remains one of the hurdles that need to be overcome if clinically sized, fully viable bone grafts are to be engineered and implanted. We discuss here the biological guidelines for tissue engineering of bone, the bioreactor cultivation of human mesenchymal stem cells on three-dimensional scaffolds, and the need for vascularization and functional integration of bone grafts following implantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370 · cited 2×
“While expression of CD34 is negative for BMSC, there are different reports for ADSC [29, 31, 35].”
BackgroundDevelopmental regulation of the growth plate
Kronenberg, H. M. (2003) · Nature · doi:10.1038/nature01657 · Cited by 2,849
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Adipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 4×
“ASC have been reported to undergo differentiation into various lineages, including osteogenic, chondrogenic and endothelial [29, 30].”
BackgroundInfluentialAn Introduction to Bioceramics
Hench, L. L., & Wilson, J. (1993) · WORLD SCIENTIFIC eBooks · doi:10.1142/2028 · Cited by 2,307
Campbell's Operative Orthopaedics
(1956) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1956.tb57228.x · Cited by 2,158
Morbidity at Bone Graft Donor Sites
Younger, E. M., & Chapman, M. W. (1989) · Journal of Orthopaedic Trauma · doi:10.1097/00005131-198909000-00002 · Cited by 2,012
Cited by
Bone Tissue Engineering: Recent Advances and Challenges
Amini, A. R., Laurencin, C. T., & Nukavarapu, S. P. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i5.10 · Cited by 2,336
Bone grafts and their substitutes
Fillingham, Y., & Jacobs, J. (2016) · The Bone & Joint Journal · doi:10.1302/0301-620x.98b.36350 · Cited by 420
Design, Materials, and Mechanobiology of Biodegradable Scaffolds for Bone Tissue Engineering
Velasco, M. A., Narváez-Tovar, C. A., & Garzón-Alvarado, D. A. (2015) · BioMed Research International · doi:10.1155/2015/729076 · Cited by 395
Role of Mesenchymal Stem Cells in Bone Regenerative Medicine: What Is the Evidence?
Oryan, A., Kamali, A., Moshiri, A., & Baghaban Eslaminejad, M. (2017) · Cells Tissues Organs · doi:10.1159/000469704 · Cited by 353
Animal models for bone tissue engineering and modelling disease
McGovern, J. A., Griffin, M., & Hutmacher, D. W. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033084 · Cited by 304
Phipps, M. C., Clem, W. C., Grunda, J. M., Clines, G. A., & Bellis, S. L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.080 · Cited by 287
“Therefore, creating a synthetic bone graft that can replace or supplement autografted bone has become a major goal in the field of tissue engineering [7,41].”
BackgroundBacterial cellulose-based scaffold materials for bone tissue engineering
Torgbo, S., & Sukyai, P. (2018) · Applied Materials Today · doi:10.1016/j.apmt.2018.01.004 · Cited by 274
Bone Grafts in Dental Medicine: An Overview of Autografts, Allografts and Synthetic Materials
Ferraz, M. P. (2023) · Materials · doi:10.3390/ma16114117 · Cited by 260
Pan, H., Zheng, Q., Yang, S., & Guo, X. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35129 · Cited by 28
Bou Assaf, R., Fayyad-Kazan, M., Al-Nemer, F., Makki, R., Fayyad-Kazan, H., Badran, B., & Berbéri, A. (2019) · BioMed Research International · doi:10.1155/2019/2868673 · Cited by 25
“Besides being nontoxic and nonimmunogenic, the structure and chemical composition of the scaffold should support cell adhesion, viability, proliferation, homing, and differentiation [10, 11].”
Background
Metadata
- Authors
- Frohlich, M., Grayson, W., Wan, L., Marolt, D., Drobnic, M., & Vunjak- Novakovic, G.
- Venue
- Current Stem Cell Research & Therapy
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-12-01
- Volume
- 3
- Issue
- 4
- Pages
- 254-264
- ISSN
- 1574-888X (ISSN-L)
- OpenAlex
- W2103338895
- Cited by
- 342
- References
- 116
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.